CIS football athlete, Quinn Smith, suspended for the presence of Stanozolol

June 3, 2014 – The Canadian Centre for Ethics in Sport (CCES) confirmed today that Quinn Smith, a Canadian Interuniversity Sport (CIS) football player, received a two-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during out-of-competition doping control on March 21, 2014, revealed the presence of stanozolol, a prohibited anabolic agent.
In response to the CCES’ notification of the adverse analytical finding, Mr. Smith waived his right to a hearing, admitted to the anti-doping rule violation, and accepted a two-year sanction ending March 21, 2016. The athlete, who resides in Scarborough, Ontario, is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates.
 
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.

Leave a comment

Please login to leave a comment.

Copyright © LawInSport Limited 2010 - 2020. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.

->